Sparsha Pharma International Private Limited, a active private limited company, was established on 12 February 2007 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2007PTC052719. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹8.56 Cr.
It upholds a compliant status. Employing 77 professional, Its leadership includes Hema Latha Devi Veerapaneni (Director), Shosaku Murayama (Director), Dange Veerapaneni (Managing Director). Past directors included Hema Latha Devi Veerapaneni, Koduru Iswara Varaprasad Reddy, Shosaku Murayama. It holds ₹1.20 Cr open charges and ₹8.00 Cr settled loans. Its latest AGM occurred on 22 August 2025, with the balance sheet filed on 31 March 2025. It is based at #44, Jalavayu Vihar, K P H B Colony, Hyderabad, Telangana, 500072.
U24232TG2007PTC052719
052719
12 February 2007
₹10.00 Cr
₹8.56 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sparsha Pharma International Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hema Latha Devi Veerapaneni | Director | 07 Sep 2007 | Current |
| Shosaku Murayama | Director | 23 Nov 2008 | Current |
| Dange Veerapaneni | Managing Director | 11 Apr 2008 | Current |
| Rajini Telaprolu | Director | 28 Feb 2025 | Current |
| Hiroyuki Kubo | Director | 26 Mar 2018 | Current |
| Bobba Venkatadri | Director | 11 Apr 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 25 Mar 2008 | Past |
| Pramod Abcsdd | Director | 05 Apr 2022 | Past |
| Pramod Abcsdd | Additional Director | 05 Sep 2009 | Past |
| Pramod Abcsdd | Director | 31 Mar 2020 | Past |
| Pramod Abcsdd | Additional Director | 11 Aug 2008 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sparsha Pharma International Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 39.31% increase. The company also saw a slight decrease in profitability, with a 1.7% decrease in profit. The company's net worth Soared by an impressive increase of 12.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sparsha Pharma International had a promoter holding of 37.57% and a public holding of 62.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹12,000,000.00
₹80,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Sep 2013 | ₹1.20 Cr | Open | |
| 06 May 2013 | Technology Developement Board | ₹8.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Sparsha Pharma International has a workforce of 77 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sparsha Pharma International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sparsha Pharma International's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sparsha Pharma International Private Limited last Annual general meeting of members was held on 22 Aug 2025 as per latest MCA records. was completed.
The activity Sparsha Pharma International Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
The activity Rajini Telaprolu was appointed as a Director was appointed as a Director on 28 Feb 2025 & has been associated with this company since 9 months 3 days . was completed.
Hiroyuki Kubo was appointed as a Director was appointed as a Director on 26 Mar 2018 & has been associated with this company since 7 years 8 months . was recorded as a recent event.
Progress on A charge registered on 06 May 2013 via Charge ID 10434203 with Technology Developement Board was fully satisfied on 10 Nov 2017. was documented.
Jayaraman Sainathan was appointed as a Company Secretary was appointed as a Company Secretary on 27 Jan 2015 & has been associated with this company since 10 years 10 months . was recorded as a recent event.
The CIN of Sparsha Pharma International Private Limited is U24232TG2007PTC052719.
Sparsha Pharma International Private Limited is headquartered at #44, Jalavayu Vihar, K P H B Colony, Hyderabad, Telangana, 500072.
Sparsha Pharma International Private Limited was incorporated on 12 February 2007.
The current directors of Sparsha Pharma International Private Limited are
The primary industry of Sparsha Pharma International Private Limited is Manufacturing.
Sparsha Pharma International Private Limited is unlisted.
The authorized capital of Sparsha Pharma International Private Limited is ₹10.00 Cr, and the paid-up capital is ₹8.56 Cr.
The compliance status of Sparsha Pharma International Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX